Vertiv Holdings Co (VRT) Stock Forecast
Data as of Jun 16, 2026Industrials · Current price $302.94 (-2.95%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 12, 2026 | Mark Delaney | Goldman Sachs | $277.00 | -8.6% |
| Feb 12, 2026 | Julian Mitchell | Barclays | $281.00 | -7.2% |
| Feb 12, 2026 | Deane Dray | RBC Capital | $266.00 | -12.2% |
| Feb 12, 2026 | Brett Linzey | Mizuho Securities | $290.00 | -4.3% |
| Jan 2, 2026 | Julian Mitchell | Barclays | $200.00 | -34.0% |
| Dec 1, 2025 | Michael Elias | Cowen & Co. | $211.00 | -30.4% |
| Oct 23, 2025 | Michael Elias | Cowen & Co. | $210.00 | -30.7% |
| Oct 23, 2025 | Christopher Snyder | Morgan Stanley | $200.00 | -34.0% |
| Oct 15, 2025 | Nicole Deblase | Deutsche Bank | $216.00 | -28.7% |
| Oct 14, 2025 | Noah Kaye | Oppenheimer | $190.00 | -37.3% |
| Jul 31, 2025 | Noah Kaye | Oppenheimer | $151.00 | -50.2% |
| Jul 16, 2025 | Brett Linzey | Mizuho Securities | $150.00 | -50.5% |
| Jul 10, 2025 | Nigel Coe | Wolfe Research | $155.00 | -48.8% |
| Nov 13, 2024 | Amit Mehrotra | UBS | $155.00 | -48.8% |
| Oct 24, 2024 | Lance Vitanza | Cowen & Co. | $115.00 | -62.0% |
| Oct 24, 2024 | Brett Linzey | Mizuho Securities | $125.00 | -58.7% |
| Oct 24, 2024 | Noah Kaye | Oppenheimer | $121.00 | -60.1% |
| Oct 23, 2024 | Amit Daryanani | Evercore ISI | $135.00 | -55.4% |
| Sep 23, 2024 | Michael Elias | Cowen & Co. | $93.00 | -69.3% |
| Sep 3, 2024 | Andrew Obin | Bank of America Securities | $115.00 | -62.0% |
Top Analysts Covering VRT
VRT vs Sector & Market
| Metric | VRT | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.41 | 2.40 |
| Analyst Count | 23 | 8 | 19 |
| Target Upside | +24.5% | +88.5% | +17.1% |
| P/E Ratio | 88.84 | 26.70 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $13.73B | $13.78B | $13.83B | 16 |
| 2027-03-31 | $3.36B | $3.44B | $3.55B | 6 |
| 2027-06-30 | $4.10B | $4.20B | $4.33B | 6 |
| 2027-09-30 | $4.46B | $4.56B | $4.71B | 6 |
| 2027-12-31 | $4.77B | $4.88B | $5.03B | 6 |
| 2028-03-31 | $3.92B | $4.01B | $4.14B | 6 |
| 2028-06-30 | $4.91B | $5.02B | $5.18B | 5 |
| 2028-09-30 | $5.30B | $5.43B | $5.60B | 5 |
| 2028-12-31 | $5.74B | $5.87B | $6.06B | 6 |
| 2029-12-31 | $19.69B | $21.52B | $23.99B | 11 |
| 2030-12-31 | $20.41B | $22.31B | $24.87B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.19 | $6.36 | $6.97 | 12 |
| 2027-03-31 | $1.52 | $1.57 | $1.63 | 5 |
| 2027-06-30 | $1.91 | $1.97 | $2.05 | 5 |
| 2027-09-30 | $2.31 | $2.38 | $2.47 | 5 |
| 2027-12-31 | $2.54 | $2.61 | $2.72 | 5 |
| 2028-03-31 | $1.85 | $1.90 | $1.98 | 6 |
| 2028-06-30 | $2.30 | $2.38 | $2.47 | 6 |
| 2028-09-30 | $2.81 | $2.90 | $3.02 | 7 |
| 2028-12-31 | $3.12 | $3.21 | $3.35 | 9 |
| 2029-12-31 | $10.13 | $11.39 | $13.09 | 2 |
| 2030-12-31 | $11.42 | $12.84 | $14.75 | 5 |
Frequently Asked Questions
What is the analyst consensus for VRT?
The consensus among 23 analysts covering Vertiv Holdings Co (VRT) is Buy with an average price target of $265.18.
What is the highest price target for VRT?
The highest price target for VRT is $290.00, set by Brett Linzey at Mizuho Securities on 2026-02-12.
What is the lowest price target for VRT?
The lowest price target for VRT is $10.00, set by Brett Linzey at Mizuho Securities on 2022-10-04.
How many analysts cover VRT?
23 analysts have issued ratings for Vertiv Holdings Co in the past 12 months.
Is VRT a buy or sell right now?
Based on 23 analyst ratings, VRT has a consensus rating of Buy (2.00/5) with a +24.5% upside to the consensus target of $265.18.
What are the earnings estimates for VRT?
Analysts estimate VRT will report EPS of $6.36 for the period ending 2026-12-31, with revenue estimated at $13.78B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.